Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PD-1/PD-L1 inhibitor ameliorates silica-induced pulmonary fibrosis by maintaining systemic immune homeostasis
Youliang Zhao, Changfu Hao, Meng Li, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 148, pp. 112768-112768
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Transforming growth factor-β signaling: From tissue fibrosis to therapeutic opportunities
Lili Ren, Xiaojun Li, Tingting Duan, et al.
Chemico-Biological Interactions (2022) Vol. 369, pp. 110289-110289
Closed Access | Times Cited: 83
The role of the immunosuppressive PD-1/PD-L1 checkpoint pathway in the aging process and age-related diseases
Antero Salminen
Journal of Molecular Medicine (2024) Vol. 102, Iss. 6, pp. 733-750
Open Access | Times Cited: 22
The role of inflammation in silicosis
Tong‐Tong Liu, Hai-Fei Sun, Yanxing Han, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 15
PD-1/PD-L1 axis in organ fibrosis
Youliang Zhao, Yaqian Qu, Changfu Hao, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 21
Expression of PD-1/PD-L1 axis in mediastinal lymph nodes and lung tissue of human and experimental lung fibrosis indicates a potential therapeutic target for idiopathic pulmonary fibrosis
Τheodoros Karampitsakos, Apostolos Galaris, Serafeim Chrysikos, et al.
Respiratory Research (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 16
Inhibitor of PD-1/PD-L1: a new approach may be beneficial for the treatment of idiopathic pulmonary fibrosis
Jie Tan, Qianfei Xue, Xiao Hu, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
PD-L1 upregulation promotes drug-induced pulmonary fibrosis by inhibiting vimentin degradation
Qing Li, Mengsheng Deng, Rentao Wang, et al.
Pharmacological Research (2022) Vol. 187, pp. 106636-106636
Open Access | Times Cited: 21
The glycyl-l-histidyl-l-lysine-Cu2+ tripeptide complex attenuates lung inflammation and fibrosis in silicosis by targeting peroxiredoxin 6
Yiding Bian, Mingming Deng, Jia Liu, et al.
Redox Biology (2024) Vol. 75, pp. 103237-103237
Open Access | Times Cited: 4
Innate immune checkpoint SIRPα/CD47 blockade ameliorates silica-induced pulmonary fibrosis by modulating macrophage immunity
Youliang Zhao, Meixiu Duan, Yuanmeng Qi, et al.
International Immunopharmacology (2025) Vol. 156, pp. 114723-114723
Closed Access
The role of PD-1/PD-L1 axis in idiopathic pulmonary fibrosis: Friend or foe?
Aimin Jiang, Na Liu, Jingjing Wang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 16
Activation of AMPK signalling by Metformin: Implication an important molecular mechanism for protecting against mice silicosis via inhibited endothelial cell-to-mesenchymal transition by regulating oxidative stress and apoptosis
Ning Li, Meiyu Chang, Qiang Zhou, et al.
International Immunopharmacology (2023) Vol. 120, pp. 110321-110321
Open Access | Times Cited: 8
Mechanotransductive receptor Piezo1 as a promising target in the treatment of fibrosis diseases
Yi Xu, Yiqian Huang, Xiaoqing Cheng, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 8
Antibody-drug conjugates for non-small cell lung cancer: Advantages and challenges in clinical translation
Chenyu Zhao, Ruihan Zhang, Huazhe Yang, et al.
Biochemical Pharmacology (2024) Vol. 226, pp. 116378-116378
Closed Access | Times Cited: 2
MALAT1-miR-30c-5p-CTGF/ATG5 axis regulates silica-induced experimental silicosis by mediating EMT in alveolar epithelial cells
Jiarui Xia, Yangyang Tian, Zheng Shao, et al.
Ecotoxicology and Environmental Safety (2022) Vol. 249, pp. 114392-114392
Open Access | Times Cited: 11
Exosomal miR-125a-5p regulates T lymphocyte subsets to promote silica-induced pulmonary fibrosis by targeting TRAF6
Mingcui Ding, Yangqing Pei, Chengpeng Zhang, et al.
Ecotoxicology and Environmental Safety (2022) Vol. 249, pp. 114401-114401
Open Access | Times Cited: 9
Silica Nanoparticles Promote the Megakaryocyte Maturation and Differentiation: Potential Implications for Hematological Homeostasis
Xiaoting Jin, Ze Zhang, Ge Guan, et al.
ACS Applied Materials & Interfaces (2023) Vol. 15, Iss. 25, pp. 29948-29957
Closed Access | Times Cited: 5
Ex vivotissue perturbations coupled to single cell RNA-seq reveal multi-lineage cell circuit dynamics in human lung fibrogenesis
Niklas J. Lang, Janine Gote-Schniering, Diana Porras-Gonzalez, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
Results from omic approaches in rat or mouse models exposed to inhaled crystalline silica: a systematic review
Laura Morin, Valérie Lecureur, Alain Lescoat
Particle and Fibre Toxicology (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 1
Inhibition of SMYD2 attenuates paraquat-induced pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition through the GLIPR2/ERK/p38 axis
Zheng Zhao, Xue Yang
Pesticide Biochemistry and Physiology (2024) Vol. 202, pp. 105971-105971
Closed Access | Times Cited: 1
Quercetin Protects against Silicon dioxide Particles-induced spleen ZBP1-Mediated PANoptosis by regulating the Nrf2/Drp1/mtDNA axis
Ke Li, Xuejiao Yang, Tong Xu, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113546-113546
Closed Access | Times Cited: 1
Idiopathic pulmonary fibrosis and lung cancer: targeting the complexity of the pharmacological interconnection
Fabio Massimo Perrotta, Vittorio Chino, Valentino Allocca, et al.
Expert Review of Respiratory Medicine (2022) Vol. 16, Iss. 10, pp. 1043-1055
Closed Access | Times Cited: 6
Low Expression of Lipoic Acid Synthase Aggravates Silica-Induced Pulmonary Fibrosis by Inhibiting the Differentiation of Tregs in Mice
Sensen Yan, Yingzheng Zhao, Jingyi Yan, et al.
Antioxidants and Redox Signaling (2023) Vol. 41, Iss. 4-6, pp. 216-232
Closed Access | Times Cited: 2
The exhaustion of lymphocytes is the main factor that decreases the sensitivity of QFT-GIT detection in silicosis
Xin Yu, Li-Na Huang, Junchi Xu, et al.
BMC Immunology (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 3
Time-series transcriptome analysis mapping pulmonary immune checkpoint atlas of experimental silicosis
Youliang Zhao, Yuanmeng Qi, Meixiu Duan, et al.
Genes & Diseases (2024) Vol. 12, Iss. 1, pp. 101258-101258
Open Access
Bioinformatics-based dynamics of cuproptosis -related indicators in experimental silicosis
Jiarui Xia, Chenchen Wu, Xiaofei Jin, et al.
Ecotoxicology and Environmental Safety (2024) Vol. 275, pp. 116286-116286
Open Access
Page 1 - Next Page

Scroll to top